When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 256-259

  Theodorescu, Dan ^a   Frierson Jr , Henry F ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; BLADDER CANCER; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TECHNIQUE; TUMOR CELL; URINARY TRACT CANCER; UROGENITAL TRACT TUMOR;

DNA, NEOPLASM; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 3242666211     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.05.001     Document Type: Conference Paper

References (19)

1. Lobban E.D., Smith B.A., Hall G.D., Harnden P., Roberts P., Selby P.J., Trejdosiewicz L.K., Southgate J. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol. 153:(6):1998;1957-1967
2. Kaufmann O., Volmerig J., Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol. 113:(5):2000;683-687
3. Wu R.L., Osman I., Wu X.R., Lu M.L., Zhang Z.F., Liang F.X., Hamza R., Scher H., Cordon-Cardo C., Sun T.T. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma alternative pathways of bladder epithelial differentiation and tumor formation [published erratum appears in Cancer Res 1998;58(13):2904]. Cancer Res. 58:(6):1998;1291-1297
4. Lu J.J., Kakehi Y., Takahashi T., Wu X.X., Yuasa T., Yoshiki T., Okada Y., Terachi T., Ogawa O. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer [In Process Citation]. Clin Cancer Res. 6:(8):2000;3166-3171
5. Yuasa T., Yoshiki T., Isono T., Tanaka T., Hayashida H., Okada Y. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol. 6:(6):1999;286-292
6. Li S.M., Zhang Z.T., Chan S., McLenan O., Dixon C., Taneja S., Lepor H., Sun T.T., Wu X.R. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. J Urol. 162:(3 Pt 1):1999;931-935
7. Moul J.W., Lewis D.J., Ross A.A., Kahn D.G., Ho C.K., McLeod D.G. Immunohistologic detection of prostate cancer pelvic lymph node micrometastases correlation to preoperative serum prostate-specific antigen. Urology. 43:(1):1994;68-73
8. Clobes H., Fossa S.D., Waehre H., Jocham D., Berner A. The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy. BJU Int. 85:(3):2000;270-275
9. Edelstein R.A., Zietman A.L., de las Morenas A., Krane R.J., Babayan R.K., Dallow K.C., Traish A., Moreland R.B. Implications of prostate micrometastases in pelvic lymph nodes an archival tissue study. Urology. 47:(3):1996;370-375
10. Ferrari A.C., Stone N.N., Eyler J.N., Gao M., Mandeli J., Unger P., Gallagher R.E., Stock R. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst. 89:(20):1997;1498-1504
11. Theodorescu D., Frierson H.F. Jr, Sikes R.A. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol. 161:(5):1999;1442-1448
12. Okegawa T., Nutahara K., Higashihara E. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer. J Urol. 163:(4):2000;1183-1188
13. Martinez-Pineiro L., Rios E., Martinez-Gomariz M., Pastor T., de Cabo M., Picazo M.L., Palacios J., Perona R. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases. Eur Urol. 43:(4):2003;342-350
14. Potter S.R., Mangold L.A., Shue M.J., Taylor D.C., Lecksell K.L., Epstein J.I., Walsh P.C., Partin A.W. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy. Cancer. 89:(12):2000;2577-2586
15. Shariat S.F., Roudier M.P., Wilcox G.E., Kattan M.W., Scardino P.T., Vessella R.L., Erdamar S., Nguyen C., Wheeler T.M., Slawin K.M. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res. 63:(15):2003;4662- 4670
16. Wawroschek F., Wagner T., Hamm M., Weckermann D., Vogt H., Markl B., Gordijn R., Harzmann R. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol. 43:(2):2003;132-136. discussion 137
17. Seraj M.J., Thomas A.R., Chin J.L., Theodorescu D. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder. Clin Cancer Res. 7:(6):2001;1516-1522
18. Retz M., Lehmann J., Szysnik C., Zwank S., Venzke T., Roder C., Kalthoff H., Basbaum C., Stockle M. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol. 45:(3):2004;314-319
19. Olsburgh J., Harnden P., Weeks R., Smith B., Joyce A., Hall G., Poulsom R., Selby P., Southgate J. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. J Pathol. 199:(1):2003;41-49